SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-009884
Filing Date
2021-02-11
Accepted
2021-02-11 19:08:35
Documents
2
Period of Report
2021-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3468
2 POA DOCUMENT poa.txt EX-24.3_962276 3208
  Complete submission text file 0001209191-21-009884.txt   8004
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Issuer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877
Business Address
Trainer John (Reporting) CIK: 0001843820 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40045 | Film No.: 21621737